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Abstract
The Esx-1 (type VII) secretion system is critical for virulence of both Mycobacterium tuberculosis and Mycobacterium marinum,
and is highly conserved between the two species. Despite its importance, there has been no direct visualization of Esx-1
secretion until now. In M. marinum, we show that secretion of Mh3864, a novel Esx-1 substrate that remains partially cell
wall–associated after translocation, occurred in polar regions, indicating that Esx-1 secretion takes place in these regions.
Analysis of Esx-1 secretion in infected host cells suggested that Esx-1 activity is similarly localized in vivo. A core component
of the Esx-1 apparatus, Mh3870, also localized to bacterial poles, showing a preference for new poles with active cell wall
peptidoglycan (PGN) synthesis. This work demonstrates that the Esx-1 secretion machine localizes to, and is active at, the
bacterial poles. Thus, virulence-related protein secretion is localized in mycobacteria, suggesting new potential therapeutic
targets, which are urgently needed.
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Introduction
Mycobacteria, and in particular M. tuberculosis, represent a
major human health problem globally [1]. The Esx-1 secretion
system [early secreted antigen 6 kilodaltons (Esat-6) secretion
system 1], which is primarily encoded by genes within, and
adjacent to, the region of difference 1 (RD1), is a major virulence
determinant of both M. tuberculosis and M. marinum, apparently
regulating bacterial spread to host cells [2–7]. In M. tuberulosis the
RD1 locus (rv3871-rv3879c) encodes the canonical Esx-1 substrates
Cfp-10 and Esat-6, as well as Rv3871 and Rv3877, two of the
three core proteins in the secretory apparatus [3,8]. The third core
constituent, Rv3870, is encoded just upstream of RD1 [3,8], but
the Rv3870 protein is not functional in the absence of this locus.
Importantly, the RD1 locus is highly conserved between M.
tuberculosis and M. marinum [4,5,9], and all Esx-1 deficient mutants
analyzed in M. marinum thus far have been functionally
complemented by their M. tuberculosis homologues, demonstrating
that the genetic conservation extends to function [5,10,11]. Thus,
M. marinum constitutes a highly relevant system in which to study
functional aspects of the Esx-1 secretion system, likely to extend to
M. tuberculosis.
It is becoming increasingly clear that pathogenic bacteria are
able to specifically localize virulence-related secretory systems and
protein secretion to distinct compartments within their cell
envelopes, and it is generally believed that such localization may
be important for virulence [12–18]. However, protein secretion
has never been visualized in mycobacteria, and it is therefore not
known whether secretion in these bacteria is compartmentalized;
in particular, there has been no visualization of Esx-1, likely
because of technical difficulties arising from the complex and
hydrophobic nature of the mycobacterial cell wall. Moreover,
analysis of this problem has not been possible because none of the
described Esx-1 substrates are known to remain associated with
the bacterial surface upon translocation, essentially precluding
their use as tools to visualize sites of active Esx-1 secretion. We
therefore sought to identify a novel Esx-1 substrate with properties
allowing such analysis, and report here that Mh3864 (Marinum
homologue of Rv3864; MMAR_5439) is such a protein. Analysis
of Mh3864 demonstrated that active Esx-1 secretion occurs in
polar regions. Furthermore, using Mh3870 (Marinum homologue
of Rv3870; MMAR_5445) as a marker for Esx-1, we show that the
secretory apparatus also localizes to the poles. Interestingly,
however, the steady-state distribution of Mh3864 in the M.
marinum cell wall is not strictly polarized, and we propose a
mechanism that may account for this feature.
Results
Mh3864 is a novel Esx-1 substrate with significant cell
wall association
In a transposon mutagenesis screen we identified an Mh3864-
insertion mutant by virtue of its smooth colony morphology, which
is a common feature of mutants affected in the Esx-1 secretion
system (Figure S1A). The Mh3864::tn mutant was deficient in
CFP-10 secretion, and exhibited modestly reduced growth in
macrophages compared to wild type M. marinum (Figure S1B and
S1C), suggesting roles for Mh3864 in Esx-1 secretion and
virulence.
To analyze the subcellular localization of Mh3864 we
fractionated M. marinum cultures into secreted fraction (culture
filtrate; CF), cell envelope fraction (Env) and cytosolic fraction
PLoS Pathogens | www.plospathogens.org 1 January 2009 | Volume 5 | Issue 1 | e1000285(Cyt) for Western blot analysis using a rabbit antiserum raised
against an 89-residue peptide derived from the C-terminal region
of Mh3864. This antiserum specifically recognized a ,40 kDa
protein species, corresponding to the expected size of Mh3864, in
all three fractions from wild type bacteria (Figure 1A, left panel).
No reactivity was observed in Mh3864::tn fractions, demonstrat-
ing specificity of the antiserum. In bacteria lacking the entire RD1-
region (DRD1), Mh3864 was produced but not secreted into the
CF, indicating that Mh3864 is a secreted protein, dependent on
Esx-1 for its export. Moreover, the specific genetic requirements
for Mh3864 secretion were very similar to those previously shown
for Cfp-10 and Esat-6, because mutants of Mh3866, Mh3867,
Mh3868, Mh3871 and Mh3881c also failed to secrete Mh3864,
whereas transposon insertions in genes encoding Mh3876,
Mh3878 or Mh3879c did not have this effect (Figure 1A, left
panel) [3,5,10,11]. Thus, Mh3864 is an Esx-1 substrate that has
significant association with the cell envelope. In mutants that failed
to secrete Mh3864, the protein was either completely absent or its
cellular concentration reduced, which might be explained by the
common finding that stability of Esx-1 constituents and substrates
appears to require an intact secretion system [5,19]. A band of
lower molecular weight appeared in the Mh3876::tn strain, which
may represent a proteolytic fragment of Mh3864. As controls we
analyzed FAP, which is secreted into the CF via the general
secretory pathway [20], and GroEL, which is not secreted into the
CF (Figure 1A, middle and right panels). These controls indicated
that none of the strains were generally deficient in protein
secretion, and that there was no nonspecific leakage of cytosolic or
envelope material into the CF. Moreover, the Mh3864-encoding
gene was transcribed in all strains except Mh3864::tn, suggesting
that the influence of Esx-1 on Mh3864 secretion/stability was
exerted at the protein level (Figure 1B).
FACS analysis demonstrated that Mh3864 was surface exposed
on wild type, but not on DRD1 bacteria (Figure 1C). Comple-
mentation with the M. tuberculosis derived RD1-2F9-cosmid
restored surface exposure [2,21]. Because Mh3864 was produced
but not secreted in DRD1 bacteria (Figure 1A and 1B), this further
indicated that Mh3864 secretion requires Esx-1 and also highlights
the functional conservation of this secretory pathway between M.
tuberculosis and M. marinum.
Active Esx-1 secretion occurs at the bacterial poles
As a fraction of Mh3864 remains surface associated upon
secretion, we hypothesized that immunofluorescence (IF) micros-
copy analysis of newly secreted Mh3864 might allow us to gain
insight into the localization of active Esx-1 secretion. To this end
we treated bacteria with trypsin, which removed Mh3864 without
killing the bacteria, and reinoculated treated cells into broth to
allow for protein synthesis. Subsequently, we fluorescently labeled
the bacterial cell wall with Ester-350 (Alexa Fluor-350 carboxylic
acid, succinimidyl ester) and probed for new Mh3864 using our
antiserum (Figure 1D and 1E). No Mh3864 staining was observed
on trypsinized bacteria (Figure S2), demonstrating that surface
exposed Mh3864 was efficiently removed. Interestingly, after
allowing for new protein synthesis in trypsinized cells, Mh3864
appeared primarily at the poles, including both old poles and new
poles formed at the division septum (Figure 1D). Analysis of many
cells demonstrated that 90% of the stained bacteria had
fluorescent foci in polar regions and 23% had foci in non-polar
regions (Figure 1E; this adds to .100% because some bacteria had
polar and non-polar foci), indicating that Esx-1 secretion occurs
primarily at the poles.
A KasB-deficient mutant strain allows for direct
visualization of the Esx-1 apparatus
The finding that newly secreted Mh3864 localized to the poles
suggested that the Esx-1 apparatus might have a polar distribution
in the cell envelope. To analyze the spatial distribution of Esx-1
directly, we generated an antiserum against Mh3870, a mem-
brane-associated component of the Esx-1 secretion apparatus.
This antiserum, raised against a 135-residue peptide correspond-
ing to amino acids 334–468, specifically recognized Mh3870 as a
,75 kDa species in the cell envelope fraction of wild type bacteria
(Figure 2A). Mh3870 reactivity was absent in DRD1, presumably
due to destabilization of the Mh3870 protein in the absence of an
intact secretory apparatus [5,19], and reappeared upon comple-
mentation with RD1-2F9. In the cytosolic fraction, the antiserum
reacted with two protein species of unknown origin. This
nonspecific reactivity was unrelated to RD1 (as it appeared in
DRD1), and does not affect analysis of the spatial distribution of
envelope-associated Mh3870, as these bands were absent from the
envelope fractions.
Anti-Mh3870 could not be used to localize Esx-1 on wild type
M. marinum, because the serum did not react with intact wild type
cells (Figure 2B, left panel). Moreover, even affinity purified anti-
Mh3870 antibodies were incompatible with methods to label thin-
sections for electron microscopy analysis (not shown). However,
Mh3870 was accessible to antibodies in a KasB-deficient mutant
strain (Figure 2B, left panel), which has a more permeable cell wall
[22]. The increased accessibility of Mh3870 in this strain was
specifically due to loss of KasB, as trans-complementation with
kasB (pKasB) eliminated the Mh3870 staining. Previous analysis of
the kasB mutation has shown that it specifically causes a 2 to 4
carbon reduction in the length of cell wall mycolic acids, which
normally are ,80 carbons long, and a slight change in the
mycolate composition. These seemingly small changes cause a
drastic increase of cell wall permeability, most likely due to effects
in the outer lipid coat of the mycobacterial cell wall where mycolic
acids are believed to reside [22].
In silico analysis of both Mh3870 and its M. tuberculosis
homologue Rv3870, which are 90% identical in primary structure,
has suggested that these proteins are integral membrane proteins
Author Summary
Mycobacteria represent a major human health problem
globally, and there is a pressing need to identify novel
processes and mechanisms including therapeutic targets.
The Esx-1 secretion system is required for both Mycobac-
terium tuberculosis and Mycobacterium marinum to cause
disease, and is absent from vaccine strains such as
Mycobacterium bovis BCG. Esx-1 is functionally conserved
between M. tuberculosis and the experimentally amenable
M. marinum, which is increasingly used to study this
secretory system. Bacterial cells are spatially highly
organized; in particular, pathogenic bacteria may localize
virulence-related protein secretion to specific regions
within the cell envelope, a feature that is generally
believed to be important for virulence. However, it has
not been known whether Esx-1 is compartmentalized. Our
work represents the first visualization of protein secretion
in mycobacteria in general. Specifically, we show that the
Esx-1 apparatus localizes to, and is active at, the bacterial
poles in M. marinum. These findings suggest previously
unappreciated mechanisms governing localization of
protein secretion in mycobacteria, potentially including
new therapeutic targets.
Polar Esx-1 Secretion in Mycobacteria
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(see Materials and Methods). The finding that Mh3870 was
accessible to antibodies on intact cells (Figure 2B, left panel)
represents the first experimental data on the topology of this
protein and strongly suggests an extracytoplasmic location for at
least some epitopes within residues 334–468. However, our data
do not exclude an intracytoplasmic location of the predicted AAA-
ATPase domain.
The subcellular localization of Mh3870 was unaffected by
absence of KasB (Figure 2A), and the amount of surface exposed
Mh3864 was similar in wild type and KasB-negative bacteria
(Figure 2B, right panel), indicating that Esx-1 secretion is
unaffected by KasB deficiency. Furthermore, IF-microscopy
analysis of newly secreted Mh3864 on KasB-negative bacteria
(Figure 2C, and Figures S2 and S3) demonstrated similar surface
distribution to wild type (Figure 1E), suggesting that kasB-
inactivation had no effect on the spatial distribution of Esx-1
secretion. Thus, the KasB-mutant could be used to study the
localization of Mh3870, as a marker for the Esx-1 apparatus.
The Esx-1 apparatus localizes to bacterial poles, with a
preference for new poles
Strikingly, IF-microscopy demonstrated that Mh3870 localized
almost exclusively to the bacterial poles (Figure 2D and 2E).
Quantification of a large number of cells indicated that staining
was specific (Figure 2E, left panel). ,96% of stained cells had
Mh3870 at a pole, while only ,12% had non-polar staining
(Figure 2E, right panel). Among the polarly stained bacteria, the
Figure 1. Mh3864 is secreted via Esx-1 in polar regions, and remains partially cell surface–associated after translocation. (A)
Indicated M. marinum strains were fractionated into culture filtrate (CF), cell envelope (Env; containing cell membrane and cell wall), and cytosolic
fractions (Cyt), and analyzed for Mh3864, FAP, and GroEL by immunoblot. (B) RNA from indicated strains was analyzed for mh3864 and groEL
transcripts by RT-PCR. No PCR products were obtained when RT-polymerase had been omitted (not shown). (C) Indicated strains were analyzed for
reactivity with anti-Mh3864 serum by FACS. As control we analyzed binding of preimmune serum from the same rabbit (preim-64) to wild type. Left
panel: Shown is a representative histogram. Right panel: Mean fluorescence intensity (MFI) was normalized to wild type reactivity with anti-Mh3864
Abs. Values are mean+/2SD of three experiments. (D) Localization of newly secreted Mh3864 was analyzed by IF-microscopy on bacteria that had
been grown for #2 generations after treatment with trypsin (0.2 mg/ml). Mh3864 was probed with anti-Mh3864 serum, and the cell wall was labeled
with Ester-350. Shown are representative wild type cells. New poles (i.e. septa) are indicated with n, and old poles with o. (E) Quantification of the
proportion of stained bacteria, from (D), that contained Mh3864 in polar and non-polar regions.
doi:10.1371/journal.ppat.1000285.g001
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the new bacterial pole (i.e. septum), indicating that Esx-1 localized
primarily to this region (Figure S4). Thus, our analysis of Mh3870
and of a newly secreted Esx-1 substrate (Mh3864) strongly
suggested that the Esx-1 apparatus localizes to, and is active at,
polar regions.
In infected host cells, the Esx-1 apparatus is active at
bacterial poles with actin tail formation
To analyze sites of Esx-1 secretion in a milieu more
representative of the mycobacterial in vivo situation, we visualized
Mh3864 localization on wild type M. marinum in infected
macrophages (Figure 3). While staining of intracellularly growing
bacteria was rare, stained cells exhibited a unipolar localization of
Mh3864. No staining was observed with preimmune serum,
demonstrating specificity (not shown). Thus, in infected host cells,
Esx-1 activity is concentrated to one of the bacterial poles,
suggesting that polarized Esx-1 secretion is relevant in vivo. Because
M. marinum has previously been shown to form actin tails at one of
their poles after reaching the cytosol of infected host cells [23], we
were also interested in examining if Esx-1 activity localized to such
poles (Figure 3). To this end we used fluorescently conjugated
phalloidin, which binds polymerized actin and allows for
visualization of actin tails. Indeed, Mh3864 localized to poles
with actin tails, indicating that the Esx-1 machine is active at poles
that are also competent to induce actin polymerization. Moreover,
because the Esx-1 machine localized primarily to new poles
(Figure 2D and Figure S4; see also Figure 5A), this also implied
that actin polymerization occurs preferentially at new bacterial
poles. While Mh3864 itself is not required for actin tail formation
(not shown), further studies are warranted to elucidate a possible
role for Esx-1, which is required for M. marinum to reach the
cytosol, in actin tail formation.
The steady-state surface distribution of Mh3864 is not
strictly polarized
IF-microscopy analysis of the steady-state distribution of
Mh3864 on GFP-expressing bacteria showed a less polarized
distribution than that of newly secreted Mh3864 (Figure 4A and
4B). As expected, wild type bacteria showed specific immunoflu-
orescence, and Mh3864::tn did not (Figure 4B, left panel). Of the
stained bacteria, 81.9% had fluorescent foci in polar regions and
53.1% had foci in non-polar regions (Figure 4B, right panel).
Similar analysis on non-GFP-expressing wild type and KasB-
negative bacteria whose walls had been fluorescently labeled with
Ester-594 confirmed this finding and also indicated that the
steady-state distribution of Mh3864 was unaffected by KasB-
deficiency (Figure 4C and Figure S5). Compared to data in
figure 4B, there was a ,10% distribution-shift towards polar
regions in the current analysis, which likely can be explained by
improved visualization of septal regions/new poles by Ester-594.
Taken together, steady-state analysis of Mh3864 (Figure 4C)
indicated a largely polarized surface distribution, but with a ,2-
fold increase of staining in non-polar regions as compared to newly
secreted Mh3864 (Figure 1E and Figure 2C). Moreover, the
steady-state distributions of Mh3870 and Mh3864 were partially
distinct; Mh3870 localized to non-polar regions in merely 12% of
stained cells (Figure 2E, right panel), whereas Mh3864 did so in
Figure 2. The Esx-1 apparatus can be studied in KasB-negative bacteria, and localizes mainly to polar regions. (A) Anti-Mh3870 serum
was used to analyze, by immunoblot, the subcellular localization of Mh3870 in fractions of indicated strains. Arrows indicate ,75 kDa. (B) Left panel:
Anti-Mh3870 serum was used for FACS-analysis of surface exposed Mh3870 on indicated strains. As control we analyzed reactivity between
preimmune serum from the same rabbit (preim-70) and KasB-negative bacteria. Right panel: Similar FACS-analysis of Mh3864. Reactivity between
wild type bacteria and preim-64 was analyzed as control. Shown are representative FACS-histograms. (C) IF-microscopy analysis of newly secreted
Mh3864; quantification of the proportion of KasB-negative bacteria that stained with anti-Mh3864 serum in polar and non-polar regions. (D) Surface
distribution of Mh3870 on KasB-negative bacteria was visualized with anti-Mh3870 serum by IF-microscopy. When possible to determine, new poles
are indicated with n, and old poles with o. (E) Left panel: IF-microscopy analysis of many cells indicated that anti-Mh3870 reactivity was specific, and
virtually no cells were stained by preim-70. Right panel: Quantification of the proportion of stained KasB-negative bacteria (83 cells) that contained
Mh3870 in polar and non-polar regions.
doi:10.1371/journal.ppat.1000285.g002
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bacterial growth, at least some Mh3864 protein moved to non-
polar regions after translocation to the cell wall at the poles.
As Mh3864 was present in distinct aggregates on the bacterial
surface, and because immunofluorescence may exaggerate the
signal from molecular aggregates, we analyzed the steady-state
distribution of surface Mh3864 by immuno transmission electron
microscopy (Figure 4D). This analysis confirmed the focal
appearance of Mh3864 on the bacterial surface, and allowed us
to analyze the distribution in more detail; ,73% of all gold
aggregates localized to polar regions while ,27% were non-
polarly distributed (Figure 4E).
The Esx-1 apparatus localizes mainly to new poles with
active cell wall growth
In order to study Esx-1 localization in more detail, and to gain
insights into the cell wall properties at these sites, we analyzed co-
localization between Mh3870 and fluorescently labeled vancomy-
cin (Vanc-FL) on Ester-350 labeled bacteria (Figure 5A). Vanco-
mycin binds to the pentapeptide precursor (Lipid II) during the
production of cell wall PGN, and it is well established that Vanc-
FL can be used to probe sites of PGN-insertion into the preexisting
cell wall [24–27]. For wild type M. marinum the MIC value of
vancomycin was exceedingly high ($80 mg/ml), and we were
unable to obtain Vanc-FL staining in these bacteria (not shown).
Figure 4. The Mh3864 protein is less polarized in the steady-state. (A) Surface Mh3864 was detected with anti-Mh3864 serum and visualized
by IF-microscopy. Shown are representative wild type cells. (B) Left panel: IF-microscopy analysis of many cells indicated that anti-Mh3864 reactivity
with wild type was specific; virtually no Mh3864::tn cells labeled with anti-Mh3864 Abs, and almost no wild type bacteria stained with preim-64. Right
panel: Quantification of the proportion of stained wild type bacteria that contained Mh3864 in polar and non-polar regions. Data are based on two
separate experiments. (C) Similar IF-microscopy analysis of Mh3864 on Ester-594 labeled wild type and KasB-negative bacteria (Mh3864 was detected
with Alexa-488 conjugated secondary Abs). (D) Immuno-TEM analysis of Mh3864 surface distribution. Bacterial strains were analyzed with anti-
Mh3864 serum or preim-64 as indicated, and IgG-binding was detected with gold-conjugated goat anti-rabbit IgG. No gold particles were observed
on controls (right panels). Mh3864 was present in aggregates on the bacterial surface (indicated with red arrows). (E) For each cell, the longest
distance between the poles (D; bacterial length) and the distance between pole 1 (defined in Methods) and individual gold aggregates (d) were
measured. The localization of each aggregate is represented as a ratio (d/D).
doi:10.1371/journal.ppat.1000285.g004
Figure 3. Esx-1 secretion occurs at poles with actin tails in the cytosol of infected host cells. Bone marrow derived mouse macrophages
where infected with GFP-expressing wild type M. marinum (green) for 24 h, and stained for Mh3864 (red) and actin tails (blue). Mh3864 was visualized
using anti-Mh3864 serum followed by Alexa fluor-594 conjugated secondary antibodies, and polymerized actin was visualized with Alexa fluor-350
conjugated phalloidin. All bacteria observed with Mh3864 staining contained Mh3864 at one pole, which was also associated with an actin tail.
Shown are three representative infected macrophages. Inlets (lower right corners) represent enlargements of bacteria with Mh3864-staining
(indicated with arrows). Of note, unspecific host-nuclear staining was observed with both anti-Mh3864 and preimmune serum (not shown).
doi:10.1371/journal.ppat.1000285.g003
Polar Esx-1 Secretion in Mycobacteria
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concentration of vancomycin (#1 mg/ml), and also stained
efficiently with Vanc-FL (Figure 5A). This analysis demonstrated
that M. marinum inserts new cell wall PGN at both new poles/septa
and old poles [27], indicating that both poles may represent
dynamic and active regions. However, new poles often stained
more intensely with Vanc-FL than old poles, suggesting that new
poles might represent more active sites of cell wall growth.
Colocalization of Mh3870 with Vanc-FL at septa (Figure 5A)
confirmed that Mh3870 localized mainly to new poles, indicating
that Esx-1 localizes primarily to a region of active cell wall
turnover.
Because our IF-microscopy analysis suggested that some
Mh3864 protein might move from its polar site of secretion
during bacterial growth, we hypothesized that Mh3864 might
move with the cell wall towards non-polar regions, as it was being
pushed from the poles by continuous insertion of new PGN. To
test if the wall migrates during bacterial growth, we stained
bacteria with Ester-594, allowed them to grow for 3 generations,
incubated the cultures with Vanc-FL, and finally stained the
bacteria with Ester-350 (Figure 5B). This allowed us to visualize
‘‘old wall’’ (Ester-594), sites of PGN-insertion (Vanc-FL), and the
‘‘current wall’’ (Ester-350). This analysis demonstrated that old
wall was absent from polar regions of PGN-insertion, whereas
staining of the current wall covered the entire bacterial surface
(Figure 5B), indicating that the old wall had indeed migrated
towards non-polar regions during bacterial growth.
Discussion
Our data demonstrate that the Esx-1 secretion apparatus
localizes to bacterial poles, primarily to new poles with active cell
wall synthesis. These findings were made possible by the use of a
mutant strain with a more permeable outer lipid coat (KasB-neg.),
which allowed penetration by antibodies and fluorescent probes.
Importantly, analysis of a novel Esx-1 substrate that remains
partially cell wall-associated (Mh3864) showed that active Esx-1
secretion occurs primarily at bacterial poles. Interestingly,
Mh3864 also localized to bacterial poles in infected macrophages,
suggesting that polarized Esx-1 secretion is relevant in the context
of an infected host. Thus, the Esx-1 apparatus localizes to, and is
active at, the bacterial poles.
The role of Mh3864 homologues in mycobacterial virulence
remains unclear. Analysis in M. tuberculosis indicates that Rv3864-
deficient bacteria are attenuated in vivo [28], whereas its
homologue in Mycobacterium leprae (ML0058c) is a pseudogene
and studies in Mycobacterium microti speak against a required role for
Rv3864 in virulence [29]. Moreover, a study in M. tuberculosis has
shown that Rv3616c (EspA), a homologue of Rv3864, is an Esx-1
substrate required for virulence [19]. Thus, although there has
been no systematic comparison of the functions of Rv3616c and
Rv3864 or their orthologues in any mycobacterial species, the
apparently conflicting data regarding the role of Rv3864 in
virulence might possibly be explained by redundancy, in at least
some mycobacterial species. Our work identifies Mh3864 as the
first bona fide Esx-1 substrate that remains partially cell surface-
associated, and accessible to antibodies on intact wild type cells,
and also suggests a role for Mh3864 in M. marinum virulence. It is
therefore intriguing to speculate that its functional homologue in
M. tuberculosis might represent a potential vaccine candidate.
Specialized secretion systems, such as Esx-1, are common
among pathogenic bacteria; for example, type III secretion is
critical for virulence of Salmonella, Shigella and Yersinia [30], and
type IV secretion is similarly required for Helicobacter, Legionella
and Agrobacterium [31]. Interestingly, the type III and type IV
secretion machines may be specifically active at bacterial poles
[15,18], implying that polar localization of virulence related
protein secretion is a common feature in pathogens. However, it
Figure 5. Esx-1 secretion occurs in polar regions, from where the cell wall PGN layer grows. (A) IF-microscopy analysis of co-localization
between Mh3870 and Vanc-FL, which labels sites of PGN-insertion into the cell wall. For visualization of PGN-insertion sites, KasB-negative bacteria
were incubated with a 1:1 mixture of vancomycin:Vanc-FL (1 mg/ml final concentration) for 4 h at 30uC. Subsequently the bacterial surface was
labeled with Ester-350, and Mh3870 (red arrows) was probed with anti-Mh3870 serum. New and old poles are indicated with n and o, respectively. (B)
KasB-negative bacteria were prepared for IF-microscopical analysis, as explained in the text, to analyze migration of old wall. When determinable, new
and old poles are indicated as described above, and those likely to represent even one generation older poles are indicated with an asterisk.
doi:10.1371/journal.ppat.1000285.g005
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secretory systems is required for virulence, possibly because the
molecular mechanisms of localization are intimately connected to
proficient secretion. Concerning mycobacteria, identification of
the genetic requirements and the mechanisms governing Esx-1
localization will open the path to address this important question.
These studies also allowed us to propose a link between cell wall
growth and Esx-1 localization. According to this model Mh3864 is
secreted via Esx-1 in polar regions with active PGN biosynthesis.
As new PGN is inserted at the poles it may push the existing cell
wall PGN layer, including associated Mh3864, towards non-polar
regions, explaining why some Mh3864 localizes to non-polar
regions during steady-state growth. However, Mh3870 remains
polarized at steady-state, emphasizing the distinct behavior of the
Esx-1 secretion machine. Interestingly, this model, which takes
into account both the site of secretion and the dynamics of cell wall
growth, is in principle similar to findings in Streptococcus pyogenes and
Listeria monocytogenes [16,25,32,33]. Thus, with regard to the steady-
state distribution of wall-associated surface proteins it appears that
a functional relationship between site of secretion and the
dynamics of cell wall growth might be of general importance in
Gram-positive bacteria, including mycobacteria.
Identification of the mechanisms governing Esx-1 localization will
be of great interest since they may be required for mycobacterial
virulence, and amenable to therapeutic intervention.
Materials and Methods
Strains and culture conditions
Wild type M. marinum M-strain and an isogenic deletion mutant
lacking RD1 (DRD1) has been described previously [34], as well as
insertional transposon mutants of Mh3866, Mh3867, Mh3868,
Mh3871, Mh3876, Mh3878, Mh3879c and Mh3881c [5,10]. An
insertional transposon mutant of KasB, and its trans-complement
(pKasB) has been described [22]. DRD1 was complemented with
RD1-2F9 by integration of this cosmid into the chromosomal attB-
site [2,21]. A wild type M. marinum M-strain expressing gfp that has
been integrated into the attB-site has been previously described
[34]. M. marinum strains were grown in Middlebrook 7H9-broth
(Difco) supplemented with 0.2% glycerol, 0.05% Tween 80, and
10% albumin-dextrose-catalase enrichment, or on 7H10 agar
(Difco) supplemented with 0.5% glycerol and 10% oleic acid-
albumin-dextrose-catalase enrichment. Cultures were supplement-
ed with antibiotics as appropriate. For fractionation of M. marinum
cultures, they were grown in Sauton’s defined medium (Teknova).
Identification of an Mh3864 transposon mutant
Wild type M. marinum expressing gfp from the chromosome was
subjected to an M
4 (mariner transposon mutagenesis in M. marinum)
mutagenesis screen as previously described in detail [35]. The site
of transposon insertion was determined as described [35]. Finally,
PCR analysis and DNA sequencing demonstrated that the
transposon was inserted in an inverted position immediately
down-stream of nucleotide 252 in the Mh3864-encoding gene,
corresponding to a truncation after amino acid 84 in Mh3864.
Fractionation of M. marinum cultures
Strains were grown to mid-log phase (OD600=0.7+/20.2) in
7H9. The bacteria were washed extensively in Sauton’s minimal
medium, and inoculated into 20 ml (final volume) of this medium.
Short-term cultures were collected ,48 h after inoculation.
Bacteria were pelleted by centrifugation, and the supernatant
was filtered through a 0.2 mm filter (culture filtrate). After a ,65-
fold concentration of the culture filtrates using Vivaspin 15R
(2.000 MWCO; Sartorius Biolab), the final volume was deter-
mined for later normalization. The bacterial pellet was weighed
for normalization purposes, and subsequently resuspended in 2 ml
fractionation buffer (100 mM HEPES, pH 7.5; 300 mM KCl;
10% glycerol; 10 mM MgCl2; 1 mM DTT; 0.01% Tween 80)
supplemented with complete, EDTA-free, protease inhibitor
coctail (Roche). Bacterial cell lysates were prepared by bead
beating at 4uC, and centrifugated at 30006g for 10 min to pellet
glass beads and remaining intact bacteria. The cell envelope
fraction, containing both the cell membrane and the cell wall, was
collected by subjecting the supernatant to ultracentrifugation
(100.0006g) for 1 h, and resuspended in 0.4 ml fractionation
buffer. The supernatant from the ultracentrifugation was collected
as cytosolic fraction, and its volume determined. For Western blot
analysis of fractions, loading was normalized to the weights of the
original bacterial pellets, and samples were separated by SDS-
PAGE, using 4–20% gradient gels (Bio-Rad). Membranes were
developed with West Pico (Pierce).
Reverse transcription PCR-analysis
RNA was purified from mid-log phase M. marinum cultures
(OD600=0.7+/20.2) using RNeasy Mini Kit (Qiagen), essentially
as described by the manufacturers. However, bacterial lysates were
first prepared by bead beating as described above, and we
included an additional step of DNase I (New England Biolabs)
treatment to ensure degradation of chromosomal DNA. C-DNA
for mh3864 and groEL were generated in the same tube by RT-
PCR on 1 mg RNA using reverse primers mh3864_3prR (59-
ttcgtcgtcttccttcttgtcgct-39) and groEL_3prR (59-tctcggtggtcagcacca-
tacgtg-39), respectively. In control tubes, RT-polymerase was
omitted; no PCR products (see below) were obtained when these
controls were used as template, demonstrating absence of
contaminating chromosomal DNA (not shown). Generated c-
DNA was used as template for PCR-analysis of mh3864 and groEL
using primer pairs mh3864_5prF (59-gctcttcaaaggaatcgccgacaa-39)
and mh3864_3prR, and groEL_5prF (59-tgagcaagctgattgagtac-
gacg-39) and groEL_3prR, respectively. Equal amounts were
loaded for gel analysis using 1% agarose gels.
Generation of antiserum to Mh3864 and Mh3870
To generate a rabbit antiserum against Mh3864, an 89-residue
peptide corresponding to amino acids 330–418 was cloned into
pGEX-KG as a translational GST-fusion. Escherichia coli BL21
Codon Plus (Stratagene) harboring the construct was grown at
37uC and expression of the fusion peptide was induced with 1 mM
IPTG. After purification on a glutathione sepharose column (GE
Healthcare) followed by an S300 column (GE Healthcare), the
GST-tag was separated off by overnight thrombin digestion that
cleaved a thrombin cleavage site located between the tag and the
Mh3864 peptide. The Mh3864 peptide was subsequently purified
through a glutathione sepharose column followed by an S200
column (GE Healthcare). A 135-residue peptide corresponding to
amino acids 334–468 of Mh3870 was expressed in a similar
manner. However, the Mh3870 fusion peptide was insoluble and
extracted from inclusion bodies by 6 M Guanidine Hydrochloride,
and refolded overnight in TRIS/HCl buffer containing 3.5 M
urea. After refolding the urea concentration was reduced to 1 M
by buffer exchange. The GST-tag was removed by thrombin
digestion as described above, and the Mh3870 peptide was
purified on a RP C4 column (W.R. GRACE). Finally, the purified
Mh3864 and Mh3870 peptides were confirmed by mass
spectrometry analysis. Rabbits were immunized with 200 mgo f
the purified peptides using TiterMax (TiterMax USA, Inc.) as
adjuvance, and subsequently similarly boosted with 100 mg
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immune response, but does not contain any mycobacterial
components. For both antigens the rabbits were also bleed prior
to immunization in order to obtain relevant preimmune controls,
and Western blot analysis of M. marinum fractions indicated lack of
reactivity for both of these preimmune sera (not shown).
Probes and antibodies
Carboxylic acid, succinimidyl esters conjugated to either Alexa
fluor-350 or 594 (Ester-350 or Ester-594), and Bodipy-conjugated
vancomycin (Vanc-FL) were from Molecular probes. For IF-
microscopy and FACS-analysis, our generated rabbit antisera
against Mh3864 and Mh3870 were used at 1:500 and 1:200,
respectively. For IF-microscopy, binding of rabbit IgG was
detected with goat anti-rabbit IgG (H+L) antibodies conjugated
with either Alexa fluor-488 or 594 (Molecular Probes), diluted to
1:250. For FACS-analysis rabbit IgG-binding was detected with an
allophycocyanin (APC)-conjugated affinity purified F(ab’)2 frag-
ment donkey anti-rabbit IgG (H+L) (Jackson ImmunoResearch
Laboratories), at 1:100. Gold (6 nm)-conjugated F(ab’)2 goat anti-
rabbit IgG (Electron Microscopy Sciences) was used at 1:200 for
electron microscopical detection of bound rabbit IgG. For
Western blotting, monoclonal mouse anti-GroEL Abs (Colorado
state) were used at 1:50, and polyclonal rabbit anti-FAP serum
(Colorado state) was used at 1:15000. Rabbit antisera against
Mh3864 and Mh3870 were used at 1:5000 and 1:2000,
respectively. Peoxidase-conjugated affinity purified F(ab’)2 frag-
ment donkey anti-rabbit IgG (H+L) (Jackson ImmunoResearch
Laboratories) and peroxidase-conjugated affinity purified F(ab’)2
fragment donkey anti-mouse IgG (H+L) (Jackson ImmunoRe-
search Laboratories) were used at 1:5000 for detection of rabbit
and mouse IgG, respectively.
Preparation of bacteria for microscopic and FACS analysis
Bacteria were grown to mid-log phase (OD600=0.7+/20.2) in
7H9-broth, and collected by centrifugation. Cells were washed in
Tris-buffered saline supplemented with 0.05% Tween-20 (TBST),
and needled twice through a 26G1/2 needle (Becton Dickinson) to
disrupt bacterial aggregates. Aggregates were pelleted by two
separate centrifugation steps (2000 rpm, 1 min), where the
supernatants, enriched for single cell bacteria, were transferred
to new tubes. The bacterial concentration was determined using a
hemacytometer, and suspensions were diluted to a final concen-
tration of ,10
8 bacteria/ml.
If the bacteria were to be stained with fluorescently conjugated
Carboxylic acid, succinimidyl ester, they were prepared in
phosphate buffered saline (PBS), and labeled as instructed by the
manufacturer. After labeling, the bacteria were washed twice with
TBST to inactivate unbound ester compounds.
Immuno fluorescence microscopic analysis
1 ml of bacterial suspensions, prepared as described above, were
pelleted and resuspended in 0.1 ml TBST containing indicated
serum/antibodies. After incubation at room temperature (RT) for
1 h with agitation, the suspensions were washed twice with TBST.
For IF-microscopy the bacteria were then similarly incubated with
the appropriate fluorescently conjugated secondary antibody.
Upon washing the bacteria were mounted with ProLong antifade
(Molecular Probes) onto glass cover slips and analyzed with
Axioplan 2 Zeis microscope using a 1006 objective. For scoring
staining as polar, the fluorescence had to be at, or immediately
adjacent to, a pole.
For visualization of Mh3864 and actin tails on M. marinum in
infected macrophages, infected cells were washed once in PBS and
fixed with 4% PFA for 20 min. Fixed cells were permeabilized
with 0.1% Triton X (Pierce) for 4 min, and subsequently washed 3
times with PBS. Mh3864 was detected by incubation with anti-
Mh3864 serum (1/100 in PBS supplemented with 1% BSA) for
1 h. After washing, a fluorescently conjugated secondary antibody
was added for visualization of IgG-binding, and Alexa Fluor-350
conjugated phalloidin (Invitrogen) was added for visualization of
polymerized actin. After 1 h incubation, cells were washed 3 times
in PBS, and mounted for IF-microscopy analysis.
FACS analysis
Bacteria were prepared as described for IF-microscopy, except
that IgG-binding was detected with APC-conjugated secondary
antibodies. Samples were run on a FACSCalibur (BD Biosciences),
and data was analyzed using FlowJo (Tree Star Inc.).
Immuno transmission electron microscopy analysis
Bacterial cells were prepared as described for IF-microscopy,
but we used a gold (6 nm) conjugated secondary antibody for
detection of bound IgG. Cells were fixed in 1/2 Karnovski’s (2%
paraformaldehyde and 2.5% glutaraldehyde in 0.1 M sodium
cacodylate buffer) for 1 h, and then washed in 0.1 M sodium
cacodylate buffer and post-fixed in 1% aqueous osmium textroxide
for 1 h. Samples were subsequently dehydrated through a series of
ethanol, followed by propylene oxide and embedded in Eponate
12 (Ted Pella). Thin sections were cut on a Reichert Ultracut E,
stained with 1% uranyl acetate and 0.1% lead citrate, and
examined in a Philips CM12 electron microscope. Images were
captured with a GATAN Retractable Multiscan digital camera.
For quantitative analysis of localization of gold aggregates, the
localization of each aggregate is represented as a ratio (d/D); the
distance between pole 1 (defined below) and individual aggregates
of gold particles (d) was divided by the longest distance between the
two bacterial poles (D). If gold particles were observed in only one
polar region, that pole is pole 1. If gold particles were observed in
both polar regions, the pole with more gold particles is pole 1. If
gold particles were observed in only non-polar regions, the pole to
the left in the picture is pole 1. Each polar region includes 25% of
the total bacterial length.
Trypsination of bacteria
For analysis of newly secreted Mh3864, bacteria were
trypsinized essentially as described previously [17,32]. In brief,
mid-log cultures were washed twice with PBS, resuspended in PBS
(untreated control) or PBS supplemented with 0.2 mg/ml trypsin
(Sigma), and incubated at 37uC for 1 h with agitation. As controls,
untreated and trypsinized cells were washed twice with TBST
supplemented with 0.02% azide (TBSTA) and immediately
probed for Mh3864 as described above. For analysis of newly
secreted Mh3864, cells were washed twice with PBS, resuspended
in 10 ml pre-warmed 7H9-medium, and grown at 32uC for #2
generations as measured by optical density. Finally these cells were
fluorescently labeled with Ester-350 and similarly probed for
Mh3864.
Macrophage infections
Bone marrow derived macrophages (BMDM) were obtained
and cultured from 129/SVJ mice as previously described [23].
BMDMs were grown on glass cover slips and infected with GFP-
expressing M. marinum at a MOI of 5, essentially as described [23].
At 24 h post infection, samples were stained for Mh3864 and actin
tails as described above. Finally, samples we mounted with
ProLong antifade for microscopical analysis.
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The ExPASy Proteomics MotifScan-tool (http://myhits.isb-sib.
ch/cgi-bin/motif_scan) was used to analyze the primary sequences
of Mh3870 (MMAR_5445) and Rv3870, which were retrieved from
MarinoList (http://genolist.pasteur.fr/ MarinoList/) and Tubercu-
List (http://genolist.pasteur.fr/ TubercuList/), respectively.
Supporting Information
Figure S1 Identification of an Mh3864-insertional transposon
mutant. (A) Left panel: Wild type M. marinum exhibits rough
colony morphology. Right panel: The Mh3864::tn mutant exhibits
smooth colony morphology, which is common to mutants affected
in Esx-1 secretion. (B) Left panel: The Mh3864::tn mutant is
unable to secrete Cfp-10, which is accumulated in the cytosol,
suggesting a role for Mh3864 in Esx-1 secretion. DRD1 was
analyzed as control. Right panel: Ag85 is secreted via the general
secretory pathway (Sec), and is unaffected by Mh3864-inactiva-
tion. Shown is representative data from three separate experi-
ments. (C) Bone marrow derived macrophages from 129/SVJ
mice were infected (MOI=3) with M. marinum, as indicated. The
Mh3864::tn mutant shows reduced growth in macrophages as
compared to wild type bacteria. As is commonly seen for mutants
of individual genes encoding Esx-1 members and/or substrates,
the growth reduction is not as severe as for the DRD1 mutant (4).
Data representative of three separate experiments.
Found at: doi:10.1371/journal.ppat.1000285.s001 (8.33 MB EPS)
Figure S2 Trypsin removes surface Mh3864. Wild type and
KasB-negative bacteria were treated with 0.2 mg/ml trypsin as
described in Materials and Methods. Untreated control and
trypsin treated bacteria were probed for Mh3864 using anti-
Mh3864 serum, and analyzed by IF-microscopy. Upper panels:
Untreated bacteria were analyzed as control and stained with anti-
Mh3864 serum. Lower panels: Virtually no trypsin treated
bacteria stained with the anti-Mh3864 serum, indicating that
trypsin efficiently removed surface Mh3864 protein.
Found at: doi:10.1371/journal.ppat.1000285.s002 (4.44 MB EPS)
Figure S3 Localization of newly secreted Mh3864 on KasB-
negative bacteria. KasB-negative bacteria were trypsinized and
reinoculated as described in Materials and Methods. Subsequently
the cellwall waslabeled with Ester-350,and Mh3864 wasprobed for
using anti-Mh3864 serum (detected with Alexa-594 conjugated
secondary Abs). KasB-negative bacteria showed similar surface
localization of newly secreted Mh3864 as wild type bacteria. For
quantitativedata,seeFigure2C.Shownherearerepresentativecells.
Found at: doi:10.1371/journal.ppat.1000285.s003 (0.57 MB EPS)
Figure S4 Detailed analysis of Mh3870 localization on KasB-
negative bacteria. The cell wall of KasB-negative bacteria was
labeled with Ester-594, and Mh3870 was localized using anti-
Mh3870 serum, detected with Alexa-488 conjugated secondary
Ab. (A) Only five principal patterns of localization are possible:
unipolar, nonpolar, unipolar and nonpolar, bipolar, and bipolar
and nonpolar. Analysis of 83 bacterial cells stained for Mh3870
indicated that 78.3% were stained exclusively in a unipolar
fashion. (B) To determine which pole (new or old) Mh3870
localized to among the unipolarly stained cells, only cells allowing
distinction between new and old poles could be used (i.e. cells with
a clearly visible division septum/new pole as illustrated in top
panels. New and old poles are indicated with n and o, respectively).
This caused the exclusion of many unipolarly stained cells, which
did not allow such determination because of lack of visible septum
(as illustrated in lower panels). Quantification of 25 bacterial cells
where new and old poles could be identified indicated that 92% of
unipolarly stained bacteria contained Mh3870 at the new pole
(bottom graph).
Found at: doi:10.1371/journal.ppat.1000285.s004 (0.78 MB EPS)
Figure S5 Steady-state distribution of Mh3864 on KasB-
negative bacteria. The cell wall of KasB-negative bacteria was
labeled with Ester-594, and Mh3864 was probed for using anti-
Mh3864 serum (detected with Alexa-488 conjugated secondary
Abs), and showed similar surface distribution as on wild type
bacteria. For quantitative data, see Figure 4C. Shown here are
representative cells.
Found at: doi:10.1371/journal.ppat.1000285.s005 (0.55 MB EPS)
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